icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
SHtCVYgjgPWmeAGk
Listen
